Date | Time | Source | Headline | Symbol | Company |
05/17/2024 | 3:00PM | iHub Newswire | FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements | | |
01/30/2024 | 9:29AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
01/26/2024 | 2:31PM | Edgar (US Regulatory) | Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
01/26/2024 | 10:46AM | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
01/22/2024 | 3:21PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
01/10/2024 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
01/03/2024 | 1:49PM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/27/2023 | 10:50AM | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 8:51PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:59PM | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:59PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:58PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:58PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:57PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:56PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:56PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:55PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/16/2023 | 1:54PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/13/2023 | 10:30AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
10/13/2023 | 8:45AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
08/14/2023 | 4:30PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
08/07/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
07/24/2023 | 4:10PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
07/20/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
07/14/2023 | 4:05PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
06/29/2023 | 4:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
06/29/2023 | 4:06PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
06/12/2023 | 6:45AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
06/09/2023 | 4:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BLPH | Bellerophon Therapeutics Inc |
06/09/2023 | 4:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BLPH | Bellerophon Therapeutics Inc |